What is the current valuation of the helicobacter pylori-test market in France?

The market valuation was $161.72 Million in 2024. Read More

What is the projected market size for the helicobacter pylori-test market in France by 2035?

The projected valuation for 2035 is $293.34 Million. Read More

What is the expected CAGR for the helicobacter pylori-test market in France during the forecast period 2025 - 2035?

The expected CAGR during this period is 5.56%. Read More

Which companies are the key players in the helicobacter pylori-test market in France?

Key players include Abbott Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche Ltd. Read More

What are the main test types available in the helicobacter pylori-test market in France?

The main test types are Non-endoscopic and Endoscopic, each valued at $80.86 Million to $146.67 Million. Read More

What technologies are utilized in the helicobacter pylori-test market in France?

Technologies include Immunoassays, Point of Care, and Molecular Diagnostics, with valuations ranging from $40.0 Million to $133.34 Million. Read More

What are the primary end users of helicobacter pylori tests in France?

Primary end users are Hospitals & Clinics, Diagnostic Laboratories, and Others, with valuations from $26.32 Million to $126.0 Million. Read More

How does the market for Molecular Diagnostics compare to other technologies in the helicobacter pylori-test market?

Molecular Diagnostics is valued at $71.72 Million to $133.34 Million, indicating a strong position compared to other technologies. Read More

What segment shows the highest valuation in the helicobacter pylori-test market in France?

The Test Type segment shows equal valuations for Non-endoscopic and Endoscopic tests, both at $80.86 Million to $146.67 Million. Read More

What trends are anticipated in the helicobacter pylori-test market in France over the next decade?

Trends suggest a steady growth trajectory, with the market likely expanding due to an expected CAGR of 5.56% from 2025 to 2035. Read More

France Helicobacter Pylori Test Market

ID: MRFR/HC/49453-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

France Helicobacter Pylori Test Market Research Report: Size, Share, Trend Analysis By Types (Non-endoscopic, Endoscopic), By Technology (Immunoassays, Point of care, Molecular Diagnostics) and By End Users (Hospitals & clinics, Diagnostic laboratories, Others) - Growth Outlook & Industry Forecast 2025 To 2035

France Helicobacter Pylori Test Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Test Type (USD Million)
  1. 4.1.1 Non-endoscopic
  2. 4.1.2 Endoscopic
2. 4.2 Pharmaceutical, BY Technology (USD Million)
  1. 4.2.1 Immunoassays
  2. 4.2.2 Point of care
  3. 4.2.3 Molecular Diagnostics
3. 4.3 Pharmaceutical, BY End User (USD Million)
  1. 4.3.1 Hospitals & clinics
  2. 4.3.2 Diagnostic laboratories
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 F. Hoffmann-La Roche Ltd (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Meridian Bioscience Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bio-Rad Laboratories Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Eiken Chemical Co Ltd (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Halyard Health Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY TEST TYPE
3. 6.3 FRANCE MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 FRANCE MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
11. 6.11 PHARMACEUTICAL, BY TEST TYPE, 2024 (% SHARE)
12. 6.12 PHARMACEUTICAL, BY TEST TYPE, 2024 TO 2035 (USD Million)
13. 6.13 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Pharmaceutical Market Segmentation

Pharmaceutical By Test Type (USD Million, 2025-2035)

Non-endoscopic
Endoscopic

Pharmaceutical By Technology (USD Million, 2025-2035)

Immunoassays
Point of care
Molecular Diagnostics

Pharmaceutical By End User (USD Million, 2025-2035)

Hospitals & clinics
Diagnostic laboratories
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”